Omar Luqmaan Harris, GM at GSK Indonesia, discusses the commitment of the Indonesian affiliate to the global organization’s mission, as well as their focus on being the best place to work, with the highest patient focus, and the best customer engagement.
Mr. Harris, what have been your main areas of focus and priorities since your appointment as head of GSK’s Indonesia operations in April 2015?
"The public market has increased its size incredibly with 50 percent growth last year as a consequence of the implementation of JKN back in 2014."
